CLAIRIgene is developing novel epigenome-targeted gene therapy for unmet medical needs in CNS disorders. Our goal is to intercept gene expression to halt the progression of devastating neurodegenerative diseases like Alzheimer's Disease, Parkinson's, and Lewy Body Dementia.
Company Details
- Employees
- 3
- Founded
- -
- Address
- The Multitude Of Effects Of Alzheimer's Disease? Stop By Our Poster At Ctad Clinical Trials On Alzheimer's Disease.
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://clairigene.com/home/
Clairigene Questions
Clairigene's website is https://clairigene.com/home/
Clairigene's LinkedIn profile is https://www.linkedin.com/company/clairigene
Clairigene has
3 employees.
View email and phone details for 3
employees at Clairigene.
Clairigene's industry is
Biotechnology Research
Clairigene's top competitors are
Reflections Water Features & Design,
Atsena Therapeutics,
Fastback Bio Llc,
Sapaugh Motors, Inc,
Cadenza Bio,
Frequency Therapies,
Otologic Pharmaceutics,
Bridgebio,
Ascend Bioventures,
Scanogen Inc..
Clairigene's categories are Biotechnology Research
Clairigene's founding year is 2019
